Latest News

COVID-19 Infection Raises Risk of Asthma and Other Respiratory Type-2 Inflammatory Diseases
COVID-19 Infection Raises Risk of Asthma and Other Respiratory Type-2 Inflammatory Diseases

August 15th 2025

Large US cohort study finds COVID-19 infection increases short-term risk of asthma, allergic rhinitis, and chronic rhinosinusitis, while vaccination lowers these risks.

Combating Vaccine Misinformation: Q&A With Amesh Adalja, MD
Combating Vaccine Misinformation: Q&A With Amesh Adalja, MD

August 14th 2025

Nirsevimab Cuts RSV Risk in Healthy Newborns: Daily Dose / image credit: ©New Africa/AdobeStock
Nirsevimab Cuts RSV Risk in Healthy Newborns: Daily Dose

August 12th 2025

FDA Accepts Priority Review of Gepotidacin for Oral Treatment of Uncomplicated Urogenital Gonorrhea / Image credit: ©MohamadFaisal/AdobeStock
FDA Accepts Gepotidacin for Priority Review for the Treatment of Uncomplicated Urogenital Gonorrhea

August 11th 2025

Nirsevimab Highly Effective in Preventing RSV-Related LRTD in Healthy Term Infants, Real-World Study Finds
Nirsevimab Highly Effective in Preventing RSV-Related LRTD in Healthy Term Infants, Real-World Study Finds

July 25th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.